Welcome to our dedicated page for Vontier Corporation news (Ticker: $VNT), a resource for investors and traders seeking the latest updates and insights on Vontier Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Vontier Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Vontier Corporation's position in the market.
Vontier (NYSE: VNT) will participate in investor conferences, with key executives engaging in fireside chats and one-on-one meetings with investors. The events include Bank of America 31st Annual Transportation, Airlines and Industrials Conference and Wolfe Research 17th Annual Global Transportation & Industrials Conference. The Bank of America presentation will be webcast live on Vontier's website.
Vontier (NYSE: VNT) reported sales of $755.8 million in Q1 2024, down 3% YoY due to divested businesses. Core sales increased by 4% driven by strong demand in various sectors. GAAP diluted net EPS was $0.88, exceeding guidance. Operating profit increased by 6% to $142.1 million. Adjusted diluted net EPS was $0.74. The company initiated Q2 2024 guidance with adjusted diluted net EPS of $0.67 to $0.71.